RWE South Korea

Document ID: PC-VN-100463

24/06/2020

Author: Boehringer Ingelheim


RWE: 1st Line Afatinib vs. 1G TKI (common+uncommon)

123,000
Views

100k 340

PC-VN-100463
Production date: June 2020